SCHEMBL24804875

SCHEMBL24804875

CNc1ccc(CC(=O)N(C)C)c(OC)c1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 1/20 0.44
POLB P06746 1/20 0.41
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
TSHR P16473 2/20 0.39
KDM4E B2RXH2 1/20 0.38
GPR55 Q9Y2T6 1/20 0.38
CYP3A4 P08684 2/20 0.38
CYP1A2 P05177 2/20 0.37
CYP2C19 P33261 2/20 0.37
CYP2D6 P10635 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
GAA P10253 2/20 0.37
SIGMAR1 Q99720 1/20 0.37
ALDH1A1 P00352 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
ERBB2 P04626 1/20 0.37
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24802505 0.88 HSD17B10 (0.44) POLBMEN1KMT2ATSHRKDM4E
SCHEMBL30772197 0.88 HSD17B10 (0.44) POLBMEN1KMT2ATSHRKDM4E
Hydrochloric Acid SCHEMBL30148685 0.87 MEN1 (0.43) POLBMEN1KMT2ATSHRKDM4E
SCHEMBL24802459 0.80 MEN1 (0.45) POLBMEN1KMT2ATSHRCYP3A4
SCHEMBL24802541 0.79 POLB (0.59) POLBMEN1KMT2AKDM4ECYP3A4
SCHEMBL19181005 0.79 GAA (0.57) POLBMEN1KMT2ATSHRKDM4E
SCHEMBL30772170 0.79 GAA (0.57) POLBMEN1KMT2ATSHRKDM4E
Hydrochloric Acid SCHEMBL30148629 0.78 GAA (0.56) POLBMEN1KMT2ATSHRKDM4E
SCHEMBL29180845 0.78 KDM4E (0.44) NR1H4POLBTSHRKDM4ESMN1; SMN2
SCHEMBL14267817 0.77 MAPT (0.44) NR1H4MEN1KMT2ATSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022268209-A1 DERIVATIVE HAVING PYRIMIDINE-FUSED CYCLIC STRUCTURE, AND USE THEREOF 四川汇宇制药股份有限公司 2022-12-29 WO disclosed